THE CLINICAL SPECTRUM OF EXCESSIVE SLEEPINESS: NEUROBIOLOGICAL MECHANISMS, ASSESSMENT, AND TREATMENT- A NARRATIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6067Keywords:
Hypersomnia, Excessive Daytime Sleepiness, Narcolepsy, Idiopathic Hypersomnia, Sleep Disorders, Sleep Physiology, Orexin, Polysomnography, Sleep MedicineAbstract
Hypersomnolence disorders constitute a heterogeneous group of conditions characterized by excessive daytime sleepiness (EDS), impaired alertness, and reduced quality of life. These disorders represent a significant medical and social challenge due to their impact on cognitive functioning, occupational performance, interpersonal relationships, and the increased risk of accidents. The regulation of sleep and wakefulness is a complex process involving interactions between circadian and homeostatic mechanisms, as well as numerous neurotransmitter systems, including orexin, dopamine, serotonin, histamine, acetylcholine, and gamma-aminobutyric acid (GABA). Advances in polysomnography, neuroimaging, and neurophysiology have improved understanding of the mechanisms underlying sleep regulation and central disorders of hypersomnolence.
This review summarizes the physiological basis of sleep, current methods used in the assessment of excessive sleepiness, and the clinical characteristics of the major hypersomnolence disorders. Particular attention is given to narcolepsy type 1 and type 2, idiopathic hypersomnia, Kleine–Levin syndrome, and hypersomnia associated with neurological, psychiatric, metabolic, endocrine, inflammatory, vascular, genetic, and traumatic conditions. Diagnostic approaches, including sleep questionnaires, actigraphy, polysomnography, and the Multiple Sleep Latency Test, are discussed in the context of differential diagnosis.
The article also reviews current therapeutic strategies, emphasizing both non-pharmacological interventions, such as sleep hygiene, scheduled naps, and behavioral modifications, and pharmacological treatments including modafinil, armodafinil, stimulants, sodium oxybate, pitolisant, and emerging therapeutic approaches targeting the orexin system. Early recognition of hypersomnolence disorders and appropriate management are essential for improving patient outcomes, reducing disease burden, and enhancing overall quality of life.
References
Szelenberger W. (2007). Neurobiology of Sleep. Advances in Respiratory Medicine, 75(I), 3-8; https://doi.org/10.5603/ARM.27934
Gandhi K., Mansukhani M., Silber M., Kolla B. (2021). Excessive Daytime Sleepiness - A Clinical Review. Mayo Clinic Proceedings, 96 (5), 1288-1301; https://doi.org/10.1016/j.mayocp.2020.08.033
Pradeep C Bollu, Sivaraman Manjamalai, Mahesh Thakkar, Pradeep Sahota. (2018). Hypersomnia. The Journal of the Missouri State Medical Association, 115(1):85–91; PMID: 30228690
Berkowski JA., Shelgikar AV. (2016). Disorders of excessive daytime sleepiness including narcolepsy and idiopathic hypersomnia. Sleep Med Clin, 11, 365-378; https://doi.org/10.1016/j.jsmc.2016.04.005
Lammers GJ., Bassetti CLA., Dolenc-Groselj L. (2020).Diagnosis of central disorders of hypersomnolence: a reappraisal by European experts. Sleep Med Rev, 52, 101-306
Sateia MJ. (2014). International Classification of Sleep Disorders-Third Edition. Chest, 146:1387-1394; https://doi.org/10.1378/chest.14-0970
Roth T. (2020). Treating excessive daytime sleepiness in patients with narcolepsy. J Clin Psychiatry, 81:HB19045BR2C; https://doi.org/10.4088/JCP.HB19045BR2C
Gaig C., Iranzo A. (2012). Sleep-disordered breathing in neurodegenerative diseases. Curr Neurol Neurosci Rep., 12:205-217; https://doi.org/10.1007/s11910-011-0248-1
Bourgin P., Zeitzer JM., Mignot E. (2008). CSF hypocretin-1 assessment in sleep and neurological disorders. Lancet Neurol.; 7:649-662; https://doi.org/10.1016/S1474-4422(08)70140-6
Bassetti CLA., Adamantidis A., Burdakov D. (2019). Narcolepsy—clinical spectrum, aetiopathophysiology, diagnosis and treatment. Nat Rev Neurol.15:519-539; https://doi.org/10.1038/s41582-019-0226-9
Merdad RA., Akil H., Wali SO. (2017). Sleepiness in adolescents. Sleep Med Clin.; 12:415-428; https://doi.org/10.1016/j.jsmc.2017.03.014
Isabelle Arnulf, Robert Thomas, Asim Roy, Yves Dauvilliers. (2023). Update on the treatment of idiopathic hypersomnia: Progress, challenges, and expert opinion. Sleep Medicine Reviews v. 69, 101766; https://doi.org/10.1016/j.smrv.2023.101766
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Zuzanna Marta Marcinkowska, Krzysztof Sebastian Habirek, Maja Maria Porażko, Anna Katarzyna Żurakowska-Zadrożna, Adrianna Krupska, Julia Anna Czarnecka, Joanna Zuzanna Gugulska, Anna Kropiwnicka, Michał Kieres, Klaudia Karolina Wójcik, Aleksander Kacper Kierys, Michał Mieczysław Parus
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
